Ipsen (STU:I7G) 3-Year Revenue Growth Rate : 7.20% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Ipsen 3-Year Revenue Growth Rate?

Ipsen's Revenue per Share for the six months ended in Dec. 2023 was €20.11.

During the past 12 months, Ipsen's average Revenue per Share Growth Rate was 4.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ipsen was 16.80% per year. The lowest was 3.60% per year. And the median was 6.30% per year.

Competitive Comparison of Ipsen's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ipsen's 3-Year Revenue Growth Rate falls into.

Ipsen 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ipsen (STU:I7G) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ipsen 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ipsen's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (STU:I7G) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (STU:I7G) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (STU:I7G) Headlines

No Headlines